Managed Healthcare Executive September 20, 2024
Logan Lutton

Participants cite the recent, ongoing popularity of GLP-1 drugs prescribed for weight loss.

Employers expect prescription drug costs to increase an average of 8% in 2025, making prices the highest they’ve been in 15 years, according to a news release published yesterday. Data was taken from the results of the 2025 Segal Health Plan Cost Trend Survey, an annual survey of managed care organizations, health insurers, prescription drug benefit managers (PBMs) and third party administrators (TPAs). Price inflation is the biggest factor on medical costs.

Respondents predict that the highest rates will be reflected in all outpatient prescription drugs with an 11.4% increase, up from last year’s projected rate of 9.9%, calculated before PBM rebates. Outpatient prescription drugs trends are...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Biotechnology, Employer, Healthcare System, Pharma, Pharma / Biotech, Pricing / Spending, Survey / Study, Trends
Related Articles:
GLP-1 drug coverage for obesity making inroads with large employers: Mercer
44% of large employers cover weight loss drugs for obesity: Mercer
Weight-loss Drug Coverage Rises Among Largest US Employers, Mercer Survey Finds
Most American adults qualify for semaglutide. Will employers cover the cost?
How AI Is Reshaping Industries And Creating Tomorrow’s Job Market

Share This Article